Category: Hematology & Oncology
Global Hematology & Oncology
-
Global Molecular Diagnostics Market Report by Technology (Chips and Microarrays, In Situ Hybridization, Sequencing, Mass Spectrometry (MS), PCR, Other Technologies) Application (Pharmacogenomics, Infectious Disease, Genetic Disease Screening, Oncology, Blood Screening, Microbiology, Human Leukocyte Antigen Typing) Product (Instruments, Reagents, Other Products) End Users (Hospitals, Laboratories, Other End Users) Countries and Company Analysis 2024-2032
... Product (Instruments, Reagents, Other Products) End Users (Hospitals, Laboratories, Other End Users) Countries and Company Analysis 2024-2032 The Global Molecular Diagnostics Market size will surpass US$ 26.27 billion by 2032 from US$ 11.88 billion in ... Read More
-
Cancer Diagnostics Global Market Opportunities And Strategies To 2033
... Colorectal Cancer; Prostate Cancer; Ovarian Cancer; Stomach Cancer3) By End User: Cancer Research Institutes; Diagnostic Laboratories; HospitalsCovering: Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Illumina Inc.; Hologic Inc. Cancer Diagnostics Global ... Read More
-
2024 Global Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Europe, Japan - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines ... Read More
-
Colorectal Cancer Screening Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... has been Compound Annual growth Rate of 4.1%.The valuation of Colorectal Cancer Screening Market Size was USD 17.05 billion in 2023 and is expected to increase from USD 17.83 Billion in 2024 to USD 24.65 ... Read More
-
Global Photoacoustic Imaging Market Size Study & Forecast, By Type (Pre-Clinical, Clinical), By Product (Photoacoustic Tomography (PAT), Photoacoustic Microscopy (PAM)), By Application (Oncology, Cardiology, Angiology, Histology, Interventional radiology), and Regional Analysis, 2023-2030
... Market is valued at approximately USD 83.04 million in 2022 and is anticipated to grow with a healthy growth rate of more than 19.27% over the forecast period 2023-2030. Photoacoustic imaging (PAI) is a cutting-edge ... Read More
-
2024 Global Forecast for Hematology Oncology Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Global Next Generation Cancer Diagnostics Databank Market Report
... 8.47% from 2023 to 2031. Next-Generation Sequencing segment is expected to be the highest contributor to this market, with $4,346.5 Million in 2022, and is anticipated to reach $9,095.4 Million by 2031, registering a CAGR ... Read More
-
Global In Vitro Diagnostics Quality Control Databank Market Report
... CAGR of 3.43% from 2023 to 2031. Immunochemistry segment is expected to be the highest contributor to this market, with $292.5 Million in 2022, and is anticipated to reach $366.9 Million by 2031, registering a ... Read More
-
Global Cancer Diagnostics Databank Market Report
... 2031. Consumables segment is expected to be the highest contributor to this market, with $167,321.8 Million in 2022, and is anticipated to reach $261,623.1 Million by 2031, registering a CAGR of 5.13%. Instruments segment is ... Read More
-
Global Hematology Diagnostics Databank Market Report
... 2031. Consumables segment is expected to be the highest contributor to this market, with $4,765.6 Million in 2022, and is anticipated to reach $7,132.2 Million by 2031, registering a CAGR of 4.62%. Instrument segment is ... Read More
-
Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Technology (Immunoassay, Molecular Diagnostics), By Application (Oncology, Nutritional & Metabolic Disease), By Region, And Segment Forecasts, 2024 - 2030
... & Trends The global laboratory developed tests market size is expected to reach USD 19.85 billion by 2030, expanding at a CAGR of 7.05% from 2024 to 2030, according to a new report by Grand ... Read More
-
Global Oncology Molecular Diagnostics Market 2024
... based on patient-specific molecular profiles. Partnerships drive innovation in molecular tests, while immuno-oncology treatments and advanced technologies improve patient outcomes. Rising cancer prevalence underscores the need for accurate diagnostics, leading to a transformation in precision ... Read More
-
Global Prostate Cancer Antigen 3 Test Market Insights, Forecast to 2030
... at a CAGR of 9.09% during 2024-2030. The US & Canada market for Prostate Cancer Antigen 3 Test is estimated to increase from $ 19.1 million in 2023 to reach $ 34.31 million by 2030, ... Read More
-
2024 Global Cancer Diagnostics Market Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
2024 Global Forecast for In-vitro diagnostic substances, hematology products (2025-2030 Outlook)-Manufacturing & Markets Report
... accurate market statistics and forecasts on the market for over 40 countries. The product category is within the NAICS 32511 industry. Estimates on equipment or material sales (product shipments value) are published historically for 2017 ... Read More
-
In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Global Forecast to 2029
... diagnostics market is projected to reach USD 119.4 billion by 2029 from USD 85.2 billion in 2024, at a CAGR of 6.9% during the forecast period. With the rapid growth in the geriatric population globally, ... Read More
-
2024 Global: Cancer Diagnostics Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Monoclonal Antibody (mABs) Therapeutics Market by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029
... projected to reach USD 497.5 billion by 2029 from an estimated USD 252.6 billion in 2024, at a CAGR of 14.5% during the forecast period. The driving factors of the monoclonal antibody therapeutics market include ... Read More
-
2024 World Hematology and Flow Cytometry Database: 98 Countries - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts
... forecasts for major hematology and flow cytometry tests, including: Hematology Tests CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, ... Read More
-
2023 Global Hematology Market Shares in the US, Europe, and Japan - Competitive Analysis of Leading and Emerging Market Players
... US. The report analyses current and emerging suppliers of hematology analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in ... Read More
-
Flow Cytometry Market Assessment, By Products and Service [Instruments, Kits and Reagents, Software and Services, Others], By Technology [Cell-based Flow Cytometry, Bead-based Flow Cytometry], By Application [Oncology, Drug Discovery, Stem Cell Therapy, Hematology, Immunology, Other Applications], By End-user [Hospitals, Clinical Testing Laboratories, Academic and Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F
... Applications], By End-user [Hospitals, Clinical Testing Laboratories, Academic and Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F Global flow cytometry market is projected to witness a CAGR of 7.89% during the forecast period 2024-2031, ... Read More
-
Immunodiagnostics Market Assessment, By Type [Radioimmunoassay, ELISA, Chemiluminescent immunoassay, Fluorescent immunoassay, Lateral flow assay, Rapid Test, Others], By Product [Reagents, Instruments, Software & Services], By Application [Oncology, Endocrinology, Infectious diseases, Allergy, Autoimmune Diseases, Environmental Pollution, Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F
... Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F Global immunodiagnostics market size was valued at ... Read More
-
Brain Cancer Diagnostics Market Size, Trends, Analysis, and Outlook By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, Platform and Services, Cerebral Arteriogram, Neurological & Hearing Tests/Neurocognitive Assessments, Electroencephalography, EEG, Others), By Cancer (Acoustic Neuroma, Astrocytomas, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, Oligodendroglioma, Low-Grade Tumors, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers & Research Institutes, Others), By Tumor Size (0.2 cm3 to 100 cm3, 101 cm3 to 200 cm3, Above 200 cm3), by Region, Country, Segment, and Companies, 2024-2030
... Neuroma, Astrocytomas, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, Oligodendroglioma, Low-Grade Tumors, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers & Research Institutes, Others), By Tumor Size (0.2 cm3 to 100 cm3, 101 ... Read More
-
Research Antibodies Market Size, Trends, Analysis, and Outlook By Product(Primary Antibodies, Secondary Antibodies), By Type(Monoclonal Antibodies,Polyclonal Antibodies), By Technology(Immunohistochemistry, Immunofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, Others), By Source(Mouse, Rabbit, Goat, Others), By Application(Infectious Diseases, Immunology, Oncology, Stem Cells, Neurobiology, Others), By End-user(Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), by Region, Country, Segment, and Companies, 2024-2030
... Immunology, Oncology, Stem Cells, Neurobiology, Others), By End-user(Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), by Region, Country, Segment, and Companies, 2024-2030 The global Research Antibodies market size is poised to register ... Read More
-
Next Generation Cancer Diagnostics Market Size, Trends, Analysis, and Outlook By Technology (Next-generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays), By Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function, Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), by Region, Country, Segment, and Companies, 2024-2030
... Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function, Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), by Region, Country, Segment, and Companies, ... Read More
Research Assistance
